Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

484
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
484
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

189
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
189
Dementia01:30

Dementia

113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
113
Survival Tree01:19

Survival Tree

85
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
85

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Community-level modeling of gyral folding patterns for robust and anatomically informed individualized brain mapping.

NeuroImage·2026
Same author

AD-GPT: large language models in Alzheimer's disease.

BMC medical informatics and decision making·2026
Same author

Large language models for bioinformatics.

Quantitative biology (Beijing, China)·2026
Same author

Biophysical modeling of anatomically realistic prenatal cortical folding development.

Research square·2026
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

A Unified Continuous Staging Framework for Alzheimer's Disease and Lewy Body Dementia via Hierarchical Anatomical Features.

Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention·2025

Related Experiment Video

Updated: Jul 3, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K

SUPERVISED DEEP TREE IN ALZHEIMER'S DISEASE.

Xiaowei Yu1, Lu Zhang1, Yanjun Lyu1

  • 1Computer Science and Engineering, University of Texas at Arlington, TX, USA.

Proceedings. IEEE International Symposium on Biomedical Imaging
|February 16, 2024
PubMed
Summary
This summary is machine-generated.

This study introduces a novel deep learning model to track Alzheimer's disease (AD) progression. The model effectively maps the continuum of AD pathology, aiding in early diagnosis and intervention strategies.

Keywords:
Alzheimer’s disease progressionfunctional connectivityindividual prediction

More Related Videos

Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials
05:54

Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials

Published on: May 10, 2024

1.4K
Transcranial Pulse Stimulation for Alzheimer's Patients
06:08

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

608

Related Experiment Videos

Last Updated: Jul 3, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.0K
Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials
05:54

Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials

Published on: May 10, 2024

1.4K
Transcranial Pulse Stimulation for Alzheimer's Patients
06:08

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

608

Area of Science:

  • Neuroscience
  • Artificial Intelligence
  • Medical Diagnostics

Background:

  • Alzheimer's disease (AD) is a progressive neurodegenerative disorder with pathological changes beginning decades before clinical symptoms.
  • Early diagnosis of AD is crucial for intervention and treatment due to the irreversible nature of its pathology.
  • Current diagnostic methods often struggle to capture the continuum of AD progression, hindering a full understanding of its mechanisms.

Purpose of the Study:

  • To develop a novel method for integrating Alzheimer's disease progression and individual prediction.
  • To model the continuum of AD pathology using a supervised deep tree model.
  • To enable more accurate predictions for new subjects based on their disease progression stage.

Main Methods:

  • Proposed a supervised deep tree model (SDTree) to represent AD progression.
  • Utilized nonlinear reversed graph embedding to model progression as a tree in a latent space.
  • Encoded the continuum of AD progression into the tree structure for analysis and prediction.

Main Results:

  • The SDTree model successfully represented the continuum of AD progression.
  • The model demonstrated capability in making predictions for new subjects.
  • Achieved promising results on a classification task using the Alzheimer's Disease Neuroimaging Initiative dataset.

Conclusions:

  • The developed SDTree model offers a new approach to understanding and predicting Alzheimer's disease progression.
  • This method enhances the ability to describe the continuum of AD pathology.
  • The findings support the potential of deep learning models for early AD diagnosis and personalized intervention.